ProPhase Labs Inc. has announced the formation of a Clinical Science Advisory Board to support the commercialization of its BE-Smart™ molecular test for esophageal disease, aimed at early ...

The advisory board will provide expert strategic guidance as ProPhase leads the regulatory and commercialization pathway for BE-Smart, with the goal of establishing a new clinical and economic ...

The Clinical Science Advisory Board will focus on accelerating clinical adoption, guiding payer education, and supporting evidence development and regulatory advancement. About ProPhase Labs Inc.

UNIONDALE, NY - ProPhase Labs Inc. (NASDAQ: PRPH), a biotech and consumer products company trading at $0.36 per share, today announced the establishment of its Clinical Science Advisory Board.

The advisory board includes Dr. Joe Abdo, the inventor of the BE-Smart test and a nationally recognized leader in molecular oncology. Dr. Abdo looks to leverage his deep relationships with academia, ...

Powered by the Science Advisory Board, BioInformatics' proprietary network of over 55,000 life science professionals, each report delivers survey-based insights on market trends, strategic shifts ...

Professor Vivian Yam has published over 10 research papers with Chemical Science over the past 10 years. As a long-serving member of the Chemical Science Advisory Board, we took this opportunity to ...

He has authored more than 300 peer-reviewed articles on air pollution and related science and has been a member of science advisory boards of the World Meteorological Organisation and UN Environment ...

For a complete list of the founding members of the Science and Technology Advisory Board, visit https://xcimer.energy/company/. About Xcimer Energy Inc.